Cost-Effectiveness Of First-Line Tyrosine Kinase Inhibitors (Tkis) In Newly Diagnosed Chronic Myeloid Leukemia (Cml) Patients In Korea- Comparison Of Dasatinib (100mg), Nilotinib (600mg) And Imatinib (400mg)
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.1177
https://www.valueinhealthjournal.com/article/S1098-3015(15)03253-2/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
675
First Page :
A458
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03253-2&doi=10.1016/j.jval.2015.09.1177